Issues related to pharmaceutical supply chain transparency and integrity. Issues related to compounding and counterfeit medicines.
Source-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 20, 2026
- Income
- $80,000.00
- Expenses
- Not reported
- Registrant
- NVG, LLC
- Client
- NOVO NORDISK INC.
- Filing UUID
- 29aabf8a-c93b-456b-b442-9020ce8c7d57
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues related to Medicare coverage of Anti-Obesity Medicines.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.